Phenotype Characterization and Course of Patients With Arrhythmogenic Right Ventricular Cardiomyopathy and Biventricular Advanced Heart Failure: A Report of 3 Cases

• Published in: Transplantation proceedings 2022-10, Vol.54 (8), p.2347-2351
• Main Authors: Bonios, Michael J., Armenis, Iakovos, Kogerakis, Nektarios, Thodou, Aspasia, Gkouziouta, Angeliki, Koliopoulou, Antigoni, Kaklamanis, Loukas, Chamogeorgakis, Themistocles, Drakos, Stavros G., Adamopoulos, Stamatis N.
• Format: Article
• Language: English
• ISSN: 0041-1345; 1873-2623
• DOI: 10.1016/j.transproceed.2022.08.047

•Arrhythmogenic right ventricular cardiomyopathy is a rare but significant cause of advanced heart failure with biventricular compromise.•Biventricular mechanical circulatory support is often necessary in low organ donation environments but with suboptimal outcomes.•Heart transplant is the advanced heart failure therapy of choice in this population. Arrhythmogenic right ventricular cardiomyopathy (ARVC) may be complicated by heart failure. Management of advanced heart failure in this context is challenging. We reviewed our center's experience with advanced heart failure therapies in patients with ARVC. Three rapidly deteriorating patients with ARVC with biventricular heart failure were found. Their management and outcomes are presented. Data on ventricular fibrosis were available in 2 of them and are also included. The first patient underwent initially successful paracorporeal pulsatile biventricular assist device (BiVAD) implantation. However, a large ischemic stroke occurred 2 weeks later, and the patient died after 2 months. The second patient underwent urgent BiVAD implantation after extracorporeal membrane oxygenation support because of cardiogenic shock, but his course was complicated by multiorgan failure due to systemic infection and the patient died. The last patient, being at Interagency Registry for Mechanically Assisted Circulatory Support 3-4 profile, underwent heart transplant with uneventful recovery. Extensive fibrosis was present in both ventricles of 2 patients undergoing pathology examination. Patients with ARVC and advanced biventricular heart failure are characterized by extensive ventricular fibrosis and considerable risk, but data on their management are limited. Biventricular circulatory support is associated with suboptimal outcomes, and prioritization for heart transplant seems preferable.